Aim-To evaluate PT derived fibrinogen determinations with reference to
Fibrinogen is an essential component of the haemostatic process, with key roles both in plasmatic clot formation' and as a cofactor in the aggregation of platelets.2 Severe fibrinogen deficiency can occur as an inherited disorder,3 as a result of reduced synthesis secondary to liver failure,4 and during consumptive coagulopathies,5 and may result in a life threatening haemorrhagic diathesis.3 Similarly, congenital and acquired dysfibrinogenaemias have been described which may lead to a bleeding or thrombotic state.' '-lo Further, high levels of normal fibrinogen are an independent risk factor in ischaemic heart disease."-13 Therefore some physicians recommend fibrinogen measurement as part of the profile of thromboembolic risk assessment, and this has created an ever increasing demand for fibrinogen assays in the clinical laboratory.
Currently the most widely used technique for determination of fibrinogen concentration is a modification of the assay described by Clauss ." In this method, dilutions of a plasma standard (of known fibrinogen concentration) are clotted with a high concentration of thrombin (-100 NIH U/ml), the clotting time being proportional to the fibrinogen concentration; the clotting time of dilute patient's plasma may then be used to read the fibrinogen concentration from the standard curve. The Clauss assay is time consuming, requiring dilution buffer and special thrombin reagent, which on some fully automated coagulation analysers may cause carryover problems in subsequent tests.
In coagulation tests, the change in light scatter or optical density during clot formation shows a progressive increase until a plateau is reached. The height of this response from the baseline is proportional to the fibrinogen concentration. Several modern photo-optical coagulometers exploit this change in optical properties during the prothrombin time reaction to determine a prothrombin time derived (PT derived) fibrinogen concentration, by comparing the response of a test plasma with that of a standard (of known fibrinogen concentration) and extrapolating the fibrinogen level."-'
In this study we undertook a comparative evaluation of Clauss fibrinogen assay versus PT derived fibrinogen determinations on the Sysmex CA-6000TM. Specific attention was paid to the source of thromboplastin employed in the prothrombin time (that is, to produce the PT derived fibrinogen), and the clinical category of patients from whom samples were obtained-for example, patients with sepsis or a hepatic disorder might have fibrin(ogen) degradation products or an acquired dysfibrinogenaemia that could disturb fibrin polym- 1) . However, there was a statistically significant difference between reagents (p < 0.0001).
Reference ranges for PT derived fibrinogen and Clauss fibrinogen determinations were established by testing plasma from 20 apparently healthy normal subjects. The ranges were found to be similar for each of these procedures (table 1) . However, the relation between PT derived fibrinogen and Clauss fibrinogen was seen to vary markedly between patient groups and was also dependent on the reagent used (fig 2) . For a more complete picture of the patients' samples analysed, ranges of PT derived fibrinogen and Clauss fibrinogen are presented in table 2.
When comparing PT derived fibrinogen results obtained using thromboplastins of different source (Innovin versus Thromboplastin IS), a good correlation was observed in each sample group (r = 0.97 to 0.99, slope = 0.76 to 1.03, intercept = 0.13 to 0.58). However, the relation between Clauss fibrinogen and PT derived fibrinogen was seen to be dependent on the sample group and the source of the thromboplastin used for the latter procedure, that is, either Innovin These observations were confirmed by statistical analysis ( The PT derived fibrinogen technique uses the difference in light scattering before and after clot formation compared with the readings taken using a standard (of known fibrinogen concentration) and extrapolates the fibrinogen concentration.'5 16 PT derived fibrinogen (as its name implies) is not therefore a direct measurement of fibrinogen and it has previously been shown to overestimate fibrinogen concentrations. '7 This study showed that results from PT derived fibrinogen differed from those obtained by the 
